4//SEC Filing
Witherspoon Charles 4
Accession 0001127602-23-026551
CIK 0000105770other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 1:37 PM ET
Size
13.1 KB
Accession
0001127602-23-026551
Insider Transaction Report
Form 4
Witherspoon Charles
VP & Treasurer
Transactions
- Exercise/Conversion
Common Stock
2023-10-31$173.22/sh+594$102,893→ 2,429.091 total - Sale
Common Stock
2023-10-31$322.27/sh−596$192,073→ 1,835.091 total - Exercise/Conversion
Common Stock
2023-10-31$274.29/sh+596$163,477→ 3,025.091 total - Sale
Common Stock
2023-10-31$322.48/sh−594$191,550→ 2,431.091 total - Exercise/Conversion
Stock Options (Right to Buy)
2023-10-31−594→ 478 totalExercise: $173.22From: 2021-02-18Exp: 2030-02-18→ Stock Options (Right to Buy) (594 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2023-10-31−596→ 596 totalExercise: $274.29From: 2022-02-23Exp: 2031-02-23→ Stock Options (Right to Buy) (596 underlying)
Footnotes (2)
- [F1]This award vests in four equal annual installments beginning on February 18, 2021.
- [F2]This award vests in four equal annual installments beginning on February 23, 2022.
Documents
Issuer
WEST PHARMACEUTICAL SERVICES INC
CIK 0000105770
Entity typeother
Related Parties
1- filerCIK 0001731739
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 1:37 PM ET
- Size
- 13.1 KB